The role of vitamin D in cardiovascular disease and COVID-19.


Journal

Reviews in endocrine & metabolic disorders
ISSN: 1573-2606
Titre abrégé: Rev Endocr Metab Disord
Pays: Germany
ID NLM: 100940588

Informations de publication

Date de publication:
04 2022
Historique:
accepted: 10 07 2021
pubmed: 3 3 2022
medline: 24 3 2022
entrez: 2 3 2022
Statut: ppublish

Résumé

Patients with pre-existing cardiovascular disease (CVD) are at high risk for adverse outcomes with coronavirus disease 2019 (COVID-19). Further, COVID-19 infection is associated with numerous cardiovascular (CV) complications including arrhythmia, myocardial injury, cardiomyopathy, and thrombotic events. Increased susceptibility to COVID-19 and CV complications related to COVID-19 may be in part related to immune dysregulation and inflammation associated with CV disease which is exacerbated with viral infection. Vitamin D plays a major role in immune function and exerts anti-inflammatory effects, which may prove important in the context of CVD and COVID-19. To date, studies have shown minimal benefit for vitamin D supplementation in patients with COVID-19, though there are no studies specific to patients with CVD and related complications. Further, given that vitamin D has important protective effects on the CV system, including augmentation of myocardial contractility and anti-thrombotic effects, it is unknown if supplementation with vitamin D can mitigate CVD complications associated with COVID-19.

Identifiants

pubmed: 35233703
doi: 10.1007/s11154-021-09674-w
pii: 10.1007/s11154-021-09674-w
pmc: PMC8888268
doi:

Substances chimiques

Vitamins 0
Vitamin D 1406-16-2

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

293-297

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

J Thromb Haemost. 2013 Mar;11(3):423-31
pubmed: 23279309
Eur J Endocrinol. 2020 Nov;183(5):R133-R147
pubmed: 32755992
Nutrients. 2015 May 29;7(6):4240-70
pubmed: 26035247
Rev Endocr Metab Disord. 2020 Dec;21(4):495-507
pubmed: 32643004
Atherosclerosis. 2014 Jul;235(1):130-9
pubmed: 24835432
J Thromb Haemost. 2014 Sep;12(9):1455-60
pubmed: 25039645
Br J Haematol. 2006 Nov;135(3):392-4
pubmed: 16984385
Eur J Heart Fail. 2011 Jun;13(6):626-32
pubmed: 21415099
Eur J Epidemiol. 2013 Mar;28(3):205-21
pubmed: 23456138
J Am Coll Cardiol. 2016 Jun 7;67(22):2593-603
pubmed: 27058906
J Am Coll Cardiol. 2020 May 12;75(18):2352-2371
pubmed: 32201335
Am Heart J. 2013 Aug;166(2):357-364.e2
pubmed: 23895820
Am J Physiol Regul Integr Comp Physiol. 2013 Nov 1;305(9):R969-77
pubmed: 24026071
Nat Rev Immunol. 2015 Feb;15(2):104-16
pubmed: 25614320
Physiol Rev. 2016 Jan;96(1):365-408
pubmed: 26681795
JAMA. 2021 Mar 16;325(11):1053-1060
pubmed: 33595634
Mol Nutr Food Res. 2010 Aug;54(8):1103-13
pubmed: 20352623
Cardiol Rev. 2011 Jul-Aug;19(4):192-201
pubmed: 21646873
Cell Host Microbe. 2009 Sep 17;6(3):231-43
pubmed: 19748465
J Steroid Biochem Mol Biol. 2020 Oct;203:105751
pubmed: 32871238
Int J Gen Med. 2014 Jun 19;7:303-9
pubmed: 24971035
Nat Rev Cardiol. 2016 Jul;13(7):404-17
pubmed: 27150190
J Clin Invest. 2017 Jan 3;127(1):1-4
pubmed: 28045402
Eur J Heart Fail. 2020 Jan;22(1):164-167
pubmed: 31797490
Prog Lipid Res. 2011 Oct;50(4):303-12
pubmed: 21640757
Obes Rev. 2015 Apr;16(4):341-9
pubmed: 25688659
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):561-565
pubmed: 32413819
Prev Med. 2010 Sep-Oct;51(3-4):228-33
pubmed: 20600257
Biochem J. 2017 Mar 24;474(8):1321-1332
pubmed: 28341729
Clin Appl Thromb Hemost. 2018 Dec;24(9_suppl):69S-75S
pubmed: 30033760
J Clin Endocrinol Metab. 2008 Oct;93(10):3927-35
pubmed: 18682515
J Am Coll Cardiol. 2020 Jun 16;75(23):2950-2973
pubmed: 32311448
Rev Endocr Metab Disord. 2017 Jun;18(2):259-272
pubmed: 28451877
Circulation. 2020 May 19;141(20):1648-1655
pubmed: 32200663
Mol Cell Biochem. 2021 Jun;476(6):2421-2427
pubmed: 33604809
Am J Clin Nutr. 2014 Sep;100(3):746-55
pubmed: 25057156
Eur J Nutr. 2021 Feb;60(1):545-548
pubmed: 32851419
JAMA Cardiol. 2020 Jul 1;5(7):831-840
pubmed: 32219363
Am J Cardiol. 2012 Sep 15;110(6):834-9
pubmed: 22658246
Br J Haematol. 2009 Jan;144(2):234-40
pubmed: 19036105
Postgrad Med J. 2022 Feb;98(1156):87-90
pubmed: 33184146
Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):819-29
pubmed: 23149428
Circulation. 2008 Jan 29;117(4):503-11
pubmed: 18180395
BMJ. 2017 Feb 15;356:i6583
pubmed: 28202713
Lancet Diabetes Endocrinol. 2020 Jul;8(7):570
pubmed: 32445630
Lancet Diabetes Endocrinol. 2014 Jan;2(1):76-89
pubmed: 24622671
N Engl J Med. 2019 Jan 3;380(1):33-44
pubmed: 30415629

Auteurs

Elissa Driggin (E)

New York-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA.

Mahesh V Madhavan (MV)

New York-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA.
Clinical Trial Center, Cardiovascular Research Foundation, New York, NY, USA.

Aakriti Gupta (A)

New York-Presbyterian Hospital and the Columbia University Irving Medical Center, New York, NY, USA. ag3786@cumc.columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH